SG Americas Securities
ARKG icon

SG Americas Securities’s ARK Genomic Revolution ETF ARKG Stock Holding History

SG Americas Securities’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$417K Sell
15,786
-86,735
-85% -$2.54M ﹤0.01% 2285
2025
Q4 		$2.97M Buy
102,521
+69,215
+208% +$2.08M ﹤0.01% 1328
2025
Q3 		$925K Buy
33,306
+1,834
+6% +$46.3K ﹤0.01% 1535
2025
Q2 		$766K Sell
31,472
-111,816
-78% -$2.45M ﹤0.01% 1346
2025
Q1 		$2.98M Buy
143,288
+112,201
+361% +$2.82M 0.01% 644
2024
Q4 		$732K Sell
31,087
-134,679
-81% -$3.31M ﹤0.01% 1041
2024
Q3 		$4.24M Buy
165,766
+36,410
+28% +$927K 0.02% 468
2024
Q2 		$3.04M Buy
129,356
+6,675
+5% +$168K 0.02% 770
2024
Q1 		$3.53M Sell
122,681
-90,378
-42% -$2.72M 0.02% 671
2023
Q4 		$6.99M Buy
213,059
+190,287
+836% +$5.17M 0.07% 271
2023
Q3 		$634K Sell
22,772
-20,727
-48% -$678K 0.01% 1587
2023
Q2 		$1.48M Sell
43,499
-12,814
-23% -$403K 0.01% 874
2023
Q1 		$1.69M Buy
56,313
+11,863
+27% +$368K 0.02% 774
2022
Q4 		$1.25M Buy
44,450
+6,562
+17% +$208K 0.02% 828
2022
Q3 		$1.25M Buy
37,888
+7,329
+24% +$269K 0.02% 872
2022
Q2 		$962K Sell
30,559
-4,887
-14% -$171K 0.01% 1327
2022
Q1 		$1.63M Sell
35,446
-8,751
-20% -$417K 0.01% 1060
2021
Q4 		$2.71M Sell
44,197
-4,795
-10% -$331K 0.01% 852
2021
Q3 		$3.66M Sell
48,992
-13,702
-22% -$1.15M 0.02% 753
2021
Q2 		$5.8M Sell
62,694
-8,410
-12% -$715K 0.03% 530
2021
Q1 		$6.31M Buy
71,104
+68,052
+2,230% +$6.75M 0.03% 426
2020
Q4 		$285K Buy
+3,052
New +$243K ﹤0.01% 2402
2019
Q2 		– Sell
-10,000
Closed -$329K – 3060
2019
Q1 		$329K Buy
+10,000
New +$295K ﹤0.01% 2190

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

SG Americas Securities's ARKG Position: Q1 2026 in Review

SG Americas Securities reduced its ARK Genomic Revolution ETF (ARKG) stake by 85% in Q1 2026, selling an estimated $2.54M and leaving 15,786 shares worth $417K. The position accounts for ﹤0.01% of the portfolio, ranked #2285.

SG Americas Securities first reported a position in ARKG in Q1 2019 and has held it in 23 quarters since. The position peaked at $6.99M in Q4 2023. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.

  • SG Americas Securities held 15,786 shares of ARK Genomic Revolution ETF worth $417K as of Q1 2026.
  • SG Americas Securities sold 86,735 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $2.54M.
  • ARK Genomic Revolution ETF made up ﹤0.01% of SG Americas Securities's portfolio in Q1 2026, its #2285 holding.
  • SG Americas Securities first reported a position in ARK Genomic Revolution ETF in Q1 2019 and has held it in 23 quarters since.
  • SG Americas Securities's ARK Genomic Revolution ETF position peaked at $6.99M in Q4 2023.
  • 218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.